Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Corey

Showing results (351-360 of 511) with videos related to

Pageof 52
Sort By:
The Journal of Infectious Diseases|February 18, 1998
Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation GroupL Corey, M J McElrath, K Weinhold, et al.
The Journal of Infectious Diseases|February 1, 1985
Cytomegalovirus infection in sex partners: evidence for sexual transmissionH H Handsfield, S H Chandler, V A Caine, et al.
Journal of Virology|May 1, 1994
Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesionsD M Koelle, L Corey, R L Burke, et al.
The Journal of Clinical Investigation|March 1, 1993
Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytesD M Koelle, M A Tigges, R L Burke, et al.
The Journal of Infectious Diseases|August 1, 1990
Anal human papillomavirus infection among human immunodeficiency virus-seropositive and -seronegative menN Kiviat, A Rompalo, R Bowden, et al.
Journal of Viral Hepatitis|September 11, 2004
Kinetics of hepatitis B viral load during 48 weeks of treatment with 600 mg vs 100 mg of lamivudine dailyC C Wang, S Holte, M-L Huang, et al.
The Journal of Infectious Diseases|January 1, 1994
Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boostingM J McElrath, L Corey, D Berger, et al.
Annals of Internal Medicine|January 10, 1998
Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trialT Schacker, H L Hu, D M Koelle, et al.
The New England Journal of Medicine|June 4, 1992
Underdiagnosis of genital herpes by current clinical and viral-isolation proceduresL A Koutsky, C E Stevens, K K Holmes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2001
Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipientsD M Zerr, T A Gooley, L Yeung, et al.
Pageof 52

Showing results (351-360 of 511) with videos related to

Sort By:
Pageof 52
The Journal of Infectious Diseases|February 18, 1998
Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation GroupL Corey, M J McElrath, K Weinhold, et al.
The Journal of Infectious Diseases|February 1, 1985
Cytomegalovirus infection in sex partners: evidence for sexual transmissionH H Handsfield, S H Chandler, V A Caine, et al.
Journal of Virology|May 1, 1994
Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesionsD M Koelle, L Corey, R L Burke, et al.
The Journal of Clinical Investigation|March 1, 1993
Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytesD M Koelle, M A Tigges, R L Burke, et al.
The Journal of Infectious Diseases|August 1, 1990
Anal human papillomavirus infection among human immunodeficiency virus-seropositive and -seronegative menN Kiviat, A Rompalo, R Bowden, et al.
Journal of Viral Hepatitis|September 11, 2004
Kinetics of hepatitis B viral load during 48 weeks of treatment with 600 mg vs 100 mg of lamivudine dailyC C Wang, S Holte, M-L Huang, et al.
The Journal of Infectious Diseases|January 1, 1994
Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boostingM J McElrath, L Corey, D Berger, et al.
Annals of Internal Medicine|January 10, 1998
Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trialT Schacker, H L Hu, D M Koelle, et al.
The New England Journal of Medicine|June 4, 1992
Underdiagnosis of genital herpes by current clinical and viral-isolation proceduresL A Koutsky, C E Stevens, K K Holmes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2001
Human herpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipientsD M Zerr, T A Gooley, L Yeung, et al.
Pageof 52